Home › Colorectal Cancer › NCT00899626

Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients

Novel Colon Cancer Markers in Gastrointestinal Tissue and Biofluids

Who can join

Ages 18 and older · All sexes

DISEASE CHARACTERISTICS:

* Undergoing colonoscopy or endoscopy for diagnostic or screening purposes at the Vanderbilt University Medical Center or at the Veterans Affairs Medical Center AND
* Meets 1 of the following criteria:

  * Diagnosis of gastrointestinal (GI) cancer, polyps, or inflammatory bowel disease
  * History of previously treated GI cancer, polyps, or inflammatory bowel disease

PATIENT CHARACTERISTICS:

* Capable of giving informed consent
* Not mentally or medically impaired
* No bleeding disorder

PRIOR CONCURRENT THERAPY:

* See Disease Characteristics

About the study

RATIONALE: Studying samples of tissue, blood, urine, stool, and other biological fluids from patients with cancer and from healthy volunteers undergoing colonoscopy or endoscopy may help doctors identify and learn more about biomarkers related to cancer.

PURPOSE: This research study is looking at gastrointestinal biomarkers in tissue and biological fluid samples from patients and participants undergoing colonoscopy, endoscopy, or surgery.

Sponsor: Vanderbilt University Medical Center · Participants: 5,000 · Started: 2002-06

Contact the study team

• Kristen K Ciombor, MD · Phone: 6159368422

Official record on ClinicalTrials.gov — NCT00899626

Locations in the U.S.

Conditions

• Colorectal Cancer
• Esophageal Cancer
• Stomach Cancer
• Pancreatic Cancer
• Precancerous Conditions
• Colon Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.